Clinicopathological Characteristics of Colorectal Cancer according to Gender Difference

다국어 초록 (Multilingual Abstract)

Background/Aims: Colorectal cancer (CRC) has been one of the major causes of death and has become a major public health concern. The incidence of CRC has been increasing regardless of gender in Korea. Until now, however, the studies on gender-based clinicopathological characteristics of CRC focused on pathology have never been reported. Therefore, we aimed to evaluate the difference in clinicopathological characteristics of CRC according to gender in Korea. Methods: Medical records of 342 patients with advanced CRC who underwent surgical resection at Kyung Hee University Hospital at Gangdong from June 2006 to December 2011 were retrospectively analyzed. The data of the clinicopathological characteristics of CRC by gender difference were compared. Results: Of these 341 patients, 203 (60%) patients were male and 138 (40%) patients were female. The male preponderance was noted in all age groups for total CRC and left-sided CRC. However, for right-sided colon cancer, this male preponderance was significantly decreased with increasing age groups (P=0.025) and was finally reversed in elderly groups (age ≥60 years). The microsatellite instability represented by negative staining for hMLH1 and hMSH2 was more frequently detected in women than men (P=0.037). Conclusions: The male preponderance in right-sided colon cancer decreased with increasing age groups and finally reversed in age groups more than 60 years. Microsatellite instability with immunohistochemical staining was more frequently detected in women. However, further studies with a large number of patients are warranted on this issue. (Intest Res 2012;10:365-371)

참고문헌 (Reference)

1 김지연, "한국 고령환자에서의 대장암의 특징 및 우측대장암의 빈도" 대한노인병학회 14 (14): 147-154, 2010

2 설미영, "난소 상피암에서 현미부수체 불안정성 분석" 대한병리학회 41 (41): 380-386, 2007

3 강원경, "결장 및 직장암에서 성별에 따른 차이점 비교" 대한대장항문학회 19 (19): 39-44, 2003

4 김병섭, "갑상선유두암에서 Galectin-3, p53, Ki-67 단백질의 발현과 임상학적 의미" 대한외과학회 77 (77): 29-36, 2009

5 Center MM, "Worldwide variations in colorectal cancer" 59 : 366-378, 2009

6 Seifert G, "The World Health Organization’s histological classification of salivary gland tumors. A commentary on the second edition" 70 : 379-385, 1992

7 Satomi A, "Significance of increased neutrophils in patients with advanced colorectal cancer" 34 : 69-73, 1995

8 Koo JH, "Sex differences in epidemiological, clinical and pathological characteristics of colorectal cancer" 25 : 33-42, 2010

9 Ratto C, "Prognostic factors in colorectal cancer. Literature review for clinical application" 41 : 1033-1049, 1998

10 Gonzalez EC, "Predictors of proximal vs. distal colorectal cancers" 44 : 251-258, 2001

11 서경진, "Platinum제로 항암 치료한 진행성 비소세포폐암종 환자에서 HER-2/neu, ERCC1과 GST-pi에 대한 연구" 대한병리학회 42 (42): 327-334, 2008

12 Nigro JM, "Mutations in the p53 gene occur in diverse human tumour types" 342 : 705-708, 1989

13 Thibodeau SN, "Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1" 58 : 1713-1718, 1998

14 Sinicrope FA, "Microsatellite instability accounts for tumor site-related differences in clinicopathologic variables and prognosis in human colon cancers" 101 : 2818-2825, 2006

15 McArdle CS, "Male gender adversely affects survival following surgery for colorectal cancer" 90 : 711-715, 2003

16 Koo JH, "Improved survival in young women with colorectal cancer" 103 : 1488-1495, 2008

17 Lanza G, "Immunohistochemical pattern of MLH1/MSH2 expression is related to clinical and pathological features in colorectal adenocarcinomas with microsatellite instability" 15 : 741-749, 2002

18 Cunningham JM, "Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability" 58 : 3455-3460, 1998

19 Vogelstein B, "Genetic alterations during colorectal-tumor development" 319 : 525-532, 1988

20 Paulson EC, "Gender influences treatment and survival in colorectal cancer surgery" 52 : 1982-1991, 2009

21 Wichmann MW, "Gender differences in long-term survival of patients with colorectal cancer" 88 : 1092-1098, 2001

22 Brenner H, "Gender differences in colorectal cancer: implications for age at initiation of screening" 96 : 828-831, 2007

23 Chen TA, "Gender differences in colorectal cancer during the past 20 years in Taiwan" 27 : 345-353, 2012

24 Wilkins HR, "Estrogen prevents sustained COLO-205 human colon cancer cell growth by inducing apoptosis, decreasing c-myb protein, and decreasing transcription of the anti-apoptotic protein bcl-2" 31 : 16-22, 2010

25 Hung HY, "Effect of preoperative neutrophil- lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy" 26 : 1059-1065, 2011

26 Bufill JA, "Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location" 113 : 779-788, 1990

27 Aaltonen LA, "Clues to the pathogenesis of familial colorectal cancer" 260 : 812-816, 1993

28 Cawkwell L, "Choice of management strategy for colorectal cancer based on a diagnostic immunohistochemical test for defective mismatch repair" 45 : 409-415, 1999

29 Cancer Statistics, "Cancer incidence" National Cancer Institute

30 Iacopetta B, "Are there two sides to colorectal cancer?" 101 : 403-408, 2002

31 Edge SB, "AJCC Cancer Staging Manual. 7th ed" Springer 2009

32 Kim HR, "A study of gender difference in colorectal cancer" 16 : 29-33, 2000